SN4
SHORT NOTE
5M
★ High-yield
Describe xerophthalmia with its WHO classification and management.
Nature and WHO Classification
- Xerophthalmia is the whole spectrum of ocular disease caused by vitamin A deficiency, from night blindness at one end to keratomalacia and irreversible blindness at the other.
- It is the leading cause of preventable childhood blindness worldwide.
| WHO grade | Feature |
|---|---|
| XN | Night blindness (nyctalopia) — the earliest sign, and fully reversible. The mother often reports that the child stumbles or will not move about at dusk |
| X1A | Conjunctival xerosis — a dry, lustreless, non-wettable conjunctiva |
| X1B |
|
| X2 | Corneal xerosis — a hazy, dry, granular cornea with a loss of lustre. Still reversible, and a medical emergency |
| X3A | Corneal ulceration or keratomalacia involving less than one-third of the corneal surface |
| X3B | Corneal ulceration or keratomalacia involving one-third or more — a rapid, painless, sterile colliquative necrosis in which the cornea melts, often within hours to days |
| XS | Corneal scar from healed xerophthalmia |
| XF | Xerophthalmic fundus — scattered yellowish-white peripheral retinal lesions |
- The critical division is between X2 and X3: everything up to corneal xerosis is reversible with treatment, and keratomalacia is not. The window is measured in days, and often in hours in a sick child
Treatment and Prevention
| Age | WHO treatment schedule — oral vitamin A |
|---|---|
| Under 6 months | 50,000 IU |
| 6 to 12 months | 100,000 IU |
| Over 12 months | 200,000 IU |
| Schedule | Given immediately on diagnosis, repeated the next day, and again after 2 weeks — the "day 1, day 2, day 14" regimen |
| Women of childbearing age | Lower doses (5,000 to 10,000 IU daily) because of teratogenicity of high-dose vitamin A in early pregnancy |
- Also essential — treat the underlying illness (measles, diarrhoea, tuberculosis); correct protein-energy malnutrition; give topical antibiotic to the cornea to prevent secondary infection, and lubricants; avoid pressure on the eye in keratomalacia, since the softened cornea will perforate; and never patch
- Prevention — periodic high-dose supplementation to children 9 months to 5 years under the national programme; promotion of breastfeeding; dietary diversification with dark green leafy vegetables, yellow and orange fruit and vegetables, milk, eggs and liver; food fortification; measles immunisation, which is among the most effective eye-saving interventions there is; and treatment of diarrhoea and worms
- In INDIA the National Programme for Prevention and Control of Blindness and the child health programme deliver vitamin A with immunisation contacts, and the prevalence of clinical xerophthalmia has fallen greatly — though subclinical deficiency persists
Applied Aspects
- Give vitamin A immediately on suspicion; do not wait for a serum level, a dietitian or a referral.
- Give vitamin A to every child with measles, whatever the eyes look like; it reduces mortality as well as blindness and is among the best-evidenced interventions in paediatrics
- Examine the eyes of every malnourished child, and ask the mother about vision at dusk; night blindness is the earliest and entirely reversible stage
All questions in Diseases of the Conjunctiva
- Q1Describe the anatomy of the conjunctiva. Classify conjunctivitis and describe the signs used to differentiate its causes. ★
- Q2Describe bacterial conjunctivitis with its types and management. ★
- Q3Describe trachoma with its grading, complications and the SAFE strategy. ★
- Q4Classify allergic conjunctivitis. Describe vernal keratoconjunctivitis and its treatment. ★
- Q5Describe viral conjunctivitis and adult inclusion conjunctivitis. ★
- SN1Describe ophthalmia neonatorum with its causes, treatment and prophylaxis. ★
- SN2Describe pterygium with its aetiology and management. ★
- SN3Describe the degenerative conditions of the conjunctiva and subconjunctival haemorrhage. ★
- SN4Describe xerophthalmia with its WHO classification and management. ★
- SN5Describe symblepharon with its causes, prevention and treatment. ★
- SN6Describe the tumours of the conjunctiva. ★
- SN7Describe conjunctival xerosis and the management of the dry ocular surface.